BIOMAT Database Logo BIOMAT Database Logo

Antiandrogenic and apoptotic effects of RU-486 on animal prostate. 2007

Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
Department of Biological Systems and Animal Production Metropolitan University-Xochimilco, Mexico D.F., Mexico. marisa@correo.xoc.uam.mx

Mifepristone (RU-486) is a potent antagonist of steroid hormone receptors such as glucocoticoid and progesterone receptors. This compound also is a very strong inducer of the interaction between androgen receptors and corepressors NCoR and SMRT and therefore could be used as selective receptor modulator. In this study we determined the relative binding affinity of RU-486 to androgen receptors (AR) obtained from rat prostate cytosol as well as the in vivo effect of different doses of RU-486 on the prostate weight of hamsters treated with dihydrotestosterone and/or RU-486. We determined also the prostate cell death (apoptosis) in hamster treated with, dihydrotestosterone (DHT) and/or RU-486. The results of this study indicated that the relative binding affinity of RU-486 for AR is 4.3%. The data from the in vivo experiments also showed that RU-486 inhibited the prostate weight significantly in the highest doses thus indicating the antagonistic action of this compound on hamster prostate. The immunohistochemistry analysis showed that after 1 month of castration, the hamster prostate was atrophic. Treatment with DHT produced epithelial cell activity (measured by the increase in the prostate weight) and very low rate of apoptosis. When DHT was administered together with RU-486 (10 mg/kg) no change was observed. On the other hand, DHT plus higher doses of RU-486 (40, 80 mg/kg) resulted in an increase of apoptosis in stromal and secretory epithelial cells. In addition to the increase of the prostate cell apoptosis produced by the treatment with high dose of RU-486, other factors could contribute to the decrease of the prostate weight observed. Another possibility could be a reduction in the ductal fluid due to poor epithelial cell secretory activity more than apoptosis itself. Furthermore, in this experiment, RU-486 could have inhibited the growth of the prostate gland produced by DHT in a greater extent than the induction of atrophy and cell death. This fact could depend on the doses used, due to the low affinity of this compound for the androgen receptors.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000726 Androgen Antagonists Compounds which inhibit or antagonize the biosynthesis or actions of androgens. Androgen Antagonist,Antiandrogen,Antiandrogens,Anti-Androgen Effect,Anti-Androgen Effects,Antiandrogen Effect,Antiandrogen Effects,Antagonist, Androgen,Antagonists, Androgen,Anti Androgen Effect,Anti Androgen Effects,Effect, Anti-Androgen,Effect, Antiandrogen,Effects, Anti-Androgen,Effects, Antiandrogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013196 Dihydrotestosterone A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. 5 alpha-Dihydrotestosterone,Androstanolone,Stanolone,17 beta-Hydroxy-5 beta-Androstan-3-One,17beta-Hydroxy-5alpha-Androstan-3-One,5 beta-Dihydrotestosterone,5-alpha Dihydrotestosterone,5-alpha-DHT,Anaprotin,Andractim,Dihydroepitestosterone,Gelovit,17 beta Hydroxy 5 beta Androstan 3 One,17beta Hydroxy 5alpha Androstan 3 One,5 alpha DHT,5 alpha Dihydrotestosterone,5 beta Dihydrotestosterone,Dihydrotestosterone, 5-alpha,beta-Hydroxy-5 beta-Androstan-3-One, 17

Related Publications

Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
Antiandrogenic effect of RU-486 in the mouse kidney.
February 1997, The international journal of biochemistry & cell biology,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
Antiandrogenic property of RU 486: enhancement of estrogen-induced uterine peroxidase activity in the rat.
April 1993, The Journal of steroid biochemistry and molecular biology,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU 486.
October 1992, American journal of public health,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU 486.
February 1995, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU 486.
June 1995, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU-486.
February 1990, JAMA,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU 486.
June 1990, Scientific American,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
[Mifegyne (RU-486)].
January 1999, Gynakologisch-geburtshilfliche Rundschau,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
[Mifepristone (RU 486)].
January 1992, Diskussionsforum medizinische Ethik,
Marisa Cabeza, and Eugene Bratoeff, and Ivonne Heuze, and Adrián Guzmán, and Georgina Gómez, and Hilda Berrios, and Ana María Rosales
RU 486 (mifepristone).
June 1992, The Western journal of medicine,
Copied contents to your clipboard!